Metformin effect on gut microbiota: insights for HIV-related inflammation

Abstract The gut microbiota is emerging as a prominent player in maintaining health through several metabolic and immune pathways. Dysregulation of gut microbiota composition, also known as dysbiosis, is involved in the clinical outcome of diabetes, inflammatory bowel diseases, cancer, aging and HIV...

Full description

Bibliographic Details
Main Authors: Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, André Marette, Bertrand Routy, Yaokai Chen, Jean-Pierre Routy
Format: Article
Language:English
Published: BMC 2020-03-01
Series:AIDS Research and Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12981-020-00267-2
_version_ 1830514971874689024
author Jing Ouyang
Stéphane Isnard
John Lin
Brandon Fombuena
André Marette
Bertrand Routy
Yaokai Chen
Jean-Pierre Routy
author_facet Jing Ouyang
Stéphane Isnard
John Lin
Brandon Fombuena
André Marette
Bertrand Routy
Yaokai Chen
Jean-Pierre Routy
author_sort Jing Ouyang
collection DOAJ
description Abstract The gut microbiota is emerging as a prominent player in maintaining health through several metabolic and immune pathways. Dysregulation of gut microbiota composition, also known as dysbiosis, is involved in the clinical outcome of diabetes, inflammatory bowel diseases, cancer, aging and HIV infection. Gut dysbiosis and inflammation persist in people living with HIV (PLWH) despite receiving antiretroviral therapy, further contributing to non-AIDS comorbidities. Metformin, a widely used antidiabetic agent, has been found to benefit microbiota composition, promote gut barrier integrity and reduce inflammation in human and animal models of diabetes. Inspired by the effect of metformin on diabetes-related gut dysbiosis, we herein critically review the relevance of metformin to control inflammation in PLWH. Metformin may improve gut microbiota composition, in turn reducing inflammation and risk of non-AIDS comorbidities. This review will pave the way towards innovative strategies to counteract dysregulated microbiota and improve the lives of PLWH.
first_indexed 2024-12-22T03:14:28Z
format Article
id doaj.art-2f1c1d85c98246118d9a27d06201f633
institution Directory Open Access Journal
issn 1742-6405
language English
last_indexed 2024-12-22T03:14:28Z
publishDate 2020-03-01
publisher BMC
record_format Article
series AIDS Research and Therapy
spelling doaj.art-2f1c1d85c98246118d9a27d06201f6332022-12-21T18:40:51ZengBMCAIDS Research and Therapy1742-64052020-03-011711910.1186/s12981-020-00267-2Metformin effect on gut microbiota: insights for HIV-related inflammationJing Ouyang0Stéphane Isnard1John Lin2Brandon Fombuena3André Marette4Bertrand Routy5Yaokai Chen6Jean-Pierre Routy7Chongqing Public Health Medical CenterInfectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health CentreInfectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health CentreInfectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health CentreDepartment of Medicine, Faculty of Medicine, Cardiology Axis of the Québec Heart and Lung Institute, Laval UniversityResearch Centre for the University of Montréal (CRCHUM)Chongqing Public Health Medical CenterInfectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health CentreAbstract The gut microbiota is emerging as a prominent player in maintaining health through several metabolic and immune pathways. Dysregulation of gut microbiota composition, also known as dysbiosis, is involved in the clinical outcome of diabetes, inflammatory bowel diseases, cancer, aging and HIV infection. Gut dysbiosis and inflammation persist in people living with HIV (PLWH) despite receiving antiretroviral therapy, further contributing to non-AIDS comorbidities. Metformin, a widely used antidiabetic agent, has been found to benefit microbiota composition, promote gut barrier integrity and reduce inflammation in human and animal models of diabetes. Inspired by the effect of metformin on diabetes-related gut dysbiosis, we herein critically review the relevance of metformin to control inflammation in PLWH. Metformin may improve gut microbiota composition, in turn reducing inflammation and risk of non-AIDS comorbidities. This review will pave the way towards innovative strategies to counteract dysregulated microbiota and improve the lives of PLWH.http://link.springer.com/article/10.1186/s12981-020-00267-2MetforminMicrobiotaGut permeabilityInflammationHIV
spellingShingle Jing Ouyang
Stéphane Isnard
John Lin
Brandon Fombuena
André Marette
Bertrand Routy
Yaokai Chen
Jean-Pierre Routy
Metformin effect on gut microbiota: insights for HIV-related inflammation
AIDS Research and Therapy
Metformin
Microbiota
Gut permeability
Inflammation
HIV
title Metformin effect on gut microbiota: insights for HIV-related inflammation
title_full Metformin effect on gut microbiota: insights for HIV-related inflammation
title_fullStr Metformin effect on gut microbiota: insights for HIV-related inflammation
title_full_unstemmed Metformin effect on gut microbiota: insights for HIV-related inflammation
title_short Metformin effect on gut microbiota: insights for HIV-related inflammation
title_sort metformin effect on gut microbiota insights for hiv related inflammation
topic Metformin
Microbiota
Gut permeability
Inflammation
HIV
url http://link.springer.com/article/10.1186/s12981-020-00267-2
work_keys_str_mv AT jingouyang metformineffectongutmicrobiotainsightsforhivrelatedinflammation
AT stephaneisnard metformineffectongutmicrobiotainsightsforhivrelatedinflammation
AT johnlin metformineffectongutmicrobiotainsightsforhivrelatedinflammation
AT brandonfombuena metformineffectongutmicrobiotainsightsforhivrelatedinflammation
AT andremarette metformineffectongutmicrobiotainsightsforhivrelatedinflammation
AT bertrandrouty metformineffectongutmicrobiotainsightsforhivrelatedinflammation
AT yaokaichen metformineffectongutmicrobiotainsightsforhivrelatedinflammation
AT jeanpierrerouty metformineffectongutmicrobiotainsightsforhivrelatedinflammation